Cardiac PET is one of the more advanced tools cardiologists have for pushing past those limits. Ijaz Ahmad has identified it ...

Late cardiotoxicity can emerge 10 or 20 years after treatment, making long-term follow-up important, particularly in patients treated during childhood.

A retrospective analysis shows that when CMR and FDG PET/CT findings are concordant, patients are more vulnerable to events.

A PET/CT radiotracer demonstrated high sensitivity and specificity for diagnosing cardiac amyloidosis, a rare disease that causes abnormal protein buildup in the heart and heart failure, according to ...

Nearly 480,000 British adults gave blood decades ago, and the pattern in those samples now looks uncomfortable. Those whose ...

Yale's AI ECG tool flags cardiac amyloidosis from a simple heart-trace photo, catching a disease with a five-year untreated ...

For someone living in Belgrade and the surrounding area, seeing a cardiologist can mean more than simply making an appointment. It may mean taking more time away from work, finding ...

A machine learning model called Amylo-Detect uses routine electronic health record data to identify patients at risk for ...

For decades, cardiologists have wrestled with a deceptively simple question: when a patient with chest pain undergoes heart ...

Regina is desperately short of nuclear medicine technologists, a situation that is delaying critical testing of everything ...

Jubilant Draximage Inc., a subsidiary of Jubilant Pharma Limited, a wholly owned subsidiary of Jubilant Pharmova Limited, has ...

During Nuclear Medicine & Molecular Imaging Week and as Lantheus marks its 70th anniversary, the company is celebrating seven decades of Massachusetts-born innovation and commitment to patients.